Informations générales (source: ClinicalTrials.gov)
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI. (IVIM-MRI)
Interventional
N/A
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
mars 2017
novembre 2018
29 juin 2024
Quantification of hepatic fibrosis by IVIM sequences in 1.5T MRI.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHU de Clermont-Ferrand - 63003 - Clermont-Ferrand - Auvergne - France | Patrick LACARIN | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients undergoing hepatic biopsy (trans-parietal or trans-jugular) in the context
of liver disease
- Signature of written consent
- Patients undergoing hepatic biopsy (trans-parietal or trans-jugular) in the context
of liver disease
- Signature of written consent
- Contra-indications to MRI
- Refusal of protocol
- Underage patients and protected adults